(Q77221798)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

P Pontisso

5

1 reference

ORCID Public Data File 2021

Alfredo Alberti

1 reference

ORCID Public Data File 2021

author name string

L Benvegnù

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

L Chemello

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

F Noventa

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

G Fattovich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

A Alberti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 September 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

901-909

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Risk factors and prevention of hepatocellular carcinoma in HCV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Hepatitis B and C viral infections in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Long-term follow-up of chronic hepatitis B patients treated with interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Long-term follow-up of patients with chronic hepatitis C treated with α-interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. The TVVH Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

The treatment of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819980901%2983%3A5%3C901%3A%3AAID-CNCR15%3E3.0.CO%3B2-Z

10.1002/(SICI)1097-0142(19980901)83:5<901::AID-CNCR15>3.0.CO;2-Z

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9731893%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference